You are here

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal

 

Online download statistics by month:

Online download statistics by month: August 2021 to September 2025

AbstractFullPdf
Aug 2021268268107
Sep 2021392393169
Oct 202122522572
Nov 202117517479
Dec 2021229231107
Jan 202212412649
Feb 2022828842
Mar 202214615179
Apr 202213414540
May 202211812166
Jun 202214014460
Jul 202210110441
Aug 202212713668
Sep 202214814950
Oct 202216416960
Nov 202210410652
Dec 202214714940
Jan 2023878743
Feb 202316516549
Mar 2023828727
Apr 2023828234
May 2023808128
Jun 2023606125
Jul 2023697245
Aug 2023747621
Sep 2023757519
Oct 202311111133
Nov 2023737422
Dec 202310110433
Jan 2024646631
Feb 2024494917
Mar 202410611057
Apr 2024858932
May 2024868640
Jun 2024646432
Jul 2024969941
Aug 2024626120
Sep 2024515229
Oct 2024565640
Nov 2024767835
Dec 2024878844
Jan 2025717135
Feb 2025676737
Mar 2025777847
Apr 202511411664
May 2025757639
Jun 2025505029
Jul 2025110
Sep 2025110
Total522153122229